Delcath Systems Inc. News

Latest updates and market news for DCTH

2 news

Nov 30 - Dec 6, 2025

Page 1

Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma

Business Wire

3 days ago

Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma

Investors in Delcath Systems (NASDAQ:DCTH) have seen splendid returns of 221% over the past three years

Simply Wall St.

3 days ago

Investors in Delcath Systems (NASDAQ:DCTH) have seen splendid returns of 221% over the past three years

➖

AI Sentiment

Neutral

5/10

Share this news page

Share on Social Networks: